Rifampicin: a review.
D000014:Abnormalities, Drug-Induced; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001424:Bacterial Infections / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007918:Leprosy / Q000188:drug therapy; D008589:Meningococcal Infections / Q000188:drug therapy; D009161:Mycobacterium; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D013922:Thrombocytosis / Q000139:chemically induced; D014376:Tuberculosis / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014570:Urologic Diseases / Q000188:drug therapy; D014780:Viruses / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D012293:Rifampin